Dublin, Jan. 29, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/32j9xh/transdermal_patch) has announced the addition of the "Transdermal Patch Markets for Specialty Materials" report to their offering.
Advances in synthetic materials and patch design have led to transdermal drug patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a small package.
Growth in demand for drug patches is being driven by several factors - factors with strong demographic and population trend underpinnings. Further improvements to transdermal transport and the introduction of new patch designs will keep this segment expanding through 2020.
Important materials markets for transdermal patches include patch backing layers, release liners, matrix materials and membranes. As patch designs expand to accommodate the need for higher drug loads in smaller packages, the role of specialty materials will remain a key design factor.
What You Will Learn
- What are the transdermal drug delivery applications for specialty materials, and what are the key application requirements?
- What are the important transdermal drug delivery market segments and who are the leading sector participants?
- What are the key transdermal patch design factors, material selection issues, technologies and performance factors?
- What is the size and share of the transdermal market for specialty materials now? What will it look like in 2020?
- How important are pres-sales engineering, application support and development partnerships for material supplier design wins?
- Who are the leading transdermal patch manufacturers, and who are their supply chain partners?
- What are the important demand drivers for specialty materials in transdermal patch applications?
Key Topics Covered:
1. Executive Summary
2. Transdermal Drug Delivery Market Dynamics
- Patch Construction
- The Patch Supply Chain
- Patch Demand Drivers
- Competitive Landscape
- Patch Manufacturing Technology
- Profiles of Patch Manufacturers
3. Transdermal Patches - Opportunities for Materials
- Applications
- Release Liners
- Backing Films
- Semi-permeable Membranes
- Adhesive Matrices
- Materials
- Polyesters
- Polyethylenes
- Polypropylenes
- Polyolefins
- Other film classes
- Coated Films
4. The Transdermal Patch Materials Market - Segment Analysis
- Patch Product Classes
- Branded Transdermal Patches
- Generic Patches
- Authorized Generic Patches
- Patch Dosing
- Daily Patches
- Three day Patches
- Weekly Patches
- Approved Patches - Construction, Composition & Materials
- Drug Reservoir Patches
- Drug-in-Adhesive Patches
- Multilaminate Patches
5. Transdermal Drug Patches - Demand Analysis & Forecasts
- Contraception
- Cardiovascular/Angina
- Depression
- Hormone Replacement Therapy
- Hypertension
- Motion Sickness
- Neurology
- Pain Management
6. Market Factors
- Patch Testing
- Clinical Trials
- FDA Materials Listing Requirements
- Regulatory Issues
- Collaboration & Partnerships
- Pre-sales Engineering and Support
7. Company Profiles
For more information visit http://www.researchandmarkets.com/research/32j9xh/transdermal_patch
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Transdermal and Transmucosal Drug Delivery


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Anthropic Eyes $350 Billion Valuation as AI Funding and Share Sale Accelerate
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings 



